FibroBiologics to Present Corporate Update at 2023 BIO International Convention
Txylo.com/10238312

Clinical ~ FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, announced that Pete O'Heeron, Founder and Chief Executive Officer, will present a corporate overview at the 2023 BIO International Convention in Boston. The presentation is set for 11:30 a.m. EDT on Tuesday, June 6, in Session Room 104A at the Boston Convention & Exhibition Center.

Mr. O'Heeron stated that they will be highlighting their recent progress in developing next-generation fibroblast cell-based therapies in multiple indications. He also expressed his excitement for the company and looks forward to connecting with members of the life sciences business community at the BIO conference. This event is considered to be one of the industry's largest and most prestigious events and FibroBiologics was selected as a presenting company that will be featured in the partnering section of the conference.

More on Txylo.com

• Texas: Governor Abbott Renews Border Disaster Declaration In September 2023
• Texas: Governor Abbott Renews Drought Disaster Declaration In September 2023
• Texas: Governor Abbott Hosts Hungarian President Novák At Governor's Mansion
• Make It Movement Launches National Marketing Pilot to Rapidly Build a New Generation of Young High-Skilled and High-Income Professionals
• U.S. Anesthesia Partners Refutes Federal Trade Commission's Misguided Allegations

Those interested in scheduling a meeting with FibroBiologics at the BIO International Convention can submit a meeting request through the BIO One-on-One Partnering™ platform or visit FibroBiologics' website or send an e-mail to FibroBiologics for more information.

---

Show All News | Report Violation